multivessel coronary artery disease

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

There was a significant interaction between treatment assignment and SYNTAX score. Patients with intermediate SYNTAX scores (23-32) demonstrated significantly greater angina relief with CABG than with

Effect: mixed; Intermediate SYNTAX (23-32): 2.8 points favoring CABG; Low SYNTAX (<=22): -0.1 points; High SYNTAX (>=33): 0.3 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points

CABG benefit over DES-PCI in angina relief was greatest among patients with daily or weekly angina at baseline (mean adjusted difference 1.8 points at 1 year), intermediate for monthly angina (1.3 poi

Effect: mixed; Daily/weekly angina: 1.8 points; Monthly angina: 1.3 points; No angina: -0.9 points